Affordable Access

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.

Authors
Type
Published Article
Journal
Archives of General Psychiatry
0003-990X
Publisher
American Medical Association
Publication Date
Volume
56
Issue
5
Pages
431–437
Identifiers
PMID: 10232298
Source
Medline
License
Unknown

Abstract

Cognitive therapy may offer an effective alternative to standard acute-phase treatment with a monoamine oxidase inhibitor for outpatients with major depressive disorder and atypical features.

Statistics

Seen <100 times